Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Topical Ruxolitinib Evaluation in Chronic Hand Eczema

ClinicalTrials.gov ID: NCT05906628

Public ClinicalTrials.gov record NCT05906628. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 1:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-Blind, Randomized, 16-Week, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Open-Label Extension Period in Adults With Chronic Hand Eczema

Study identification

NCT ID
NCT05906628
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Incyte Corporation
Industry
Enrollment
186 participants

Conditions and interventions

Conditions

Interventions

  • Ruxolitinib cream Drug
  • Vehicle Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 30, 2023
Primary completion
Jul 14, 2024
Completion
Dec 12, 2024
Last update posted
Jul 30, 2025

2023 – 2024

United States locations

U.S. sites
23
U.S. states
15
U.S. cities
21
Facility City State ZIP Site status
Southwest Skin Specialists Phoenix Biltmore Phoenix Arizona 85018
First Oc Dermatology Fountain Valley California 92708
Marvel Clinical Research Llc Huntington Beach California 92647
Dermatology Research Associates Los Angeles California 90045
Skin Research of South Florida, Llc Miami Florida 33173
Well Pharma Medical Research Corporation Miami Florida 33173
Forcare Clinical Research Tampa Florida 33613
Midwest Allergy Sinus Asthma, Sc Normal Illinois 61761
The Indiana Clinical Trials Center Ictc Plainfield Indiana 46168
Delricht Research Baton Rouge Louisiana 70809
Delricht Research New Orleans Louisiana 70115
Henry Ford Medical Center Detroit Michigan 48084
Jubilee Clinical Research Inc Las Vegas Nevada 89106
Forest Hills Dermatology Group Kew Gardens New York 11415
Juva Skin and Laser Center New York New York 10022
Onsite Clinical Solutions, Llc Charlotte Central Office Charlotte North Carolina 28277
Bexley Dermatology Bexley Ohio 43209
Central Sooner Research Oklahoma City Oklahoma 73118
Oregon Dermatology and Research Center Portland Oregon 97210
Oregon Medical Research Center Portland Oregon 97223
International Clinical Research Tennessee Llc Murfreesboro Tennessee 37130
Austin Institute For Clinical Research Aicr Pflugerville Pflugerville Texas 78660
Dermatology Clinical Research Center of San Antonio San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05906628, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 30, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05906628 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →